#030: ECTRIMS 2023. 10 Hot Topics and my highlights of day 1

#030: ECTRIMS 2023. 10 Hot Topics and my highlights of day 1

Overview on the hot topics of ECTRIMS 2023 and detailed look into the vision of curing MS, MS and EBV and MS in the elderly.

you can read the full text with some more details on the statistics of the trials on my blog: https://ms-perspektive.com/030-ectrims-2023-day-1

MS Milan 2023 was the 9th joint meeting of the European ECTRIMS and American ACTRIMS congress. Over 8,600 participants from 108 countries joined and had the chance to listen to 240 faculty members and diggest the input from 1,915 abstracts.

Ten hot topics where defined:

  1. MS and EBV
  2. Treatment screening and monitoring
  3. MS in the elderly
  4. Which biomarker and when?
  5. Future therapeutic strategies
  6. PIRA and silent progression
  7. New technologies for MS patients
  8. Prodromic MS
  9. HSCT in MS
  10. Biomarkers of damage and recovery

I will try to pick some interesting outcomes on most of them during my summary of the three days starting with the the ECTRIMS lecture by Dr. Stephen L. Hauser and continuing with MS and EBV, and MS in the elderly.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(192)

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

#190: Living with multiple sclerosis. Gabriela's story and the "(un)seen faces of MS" Art Project

https://ms-perspektive.de/en/190-unseen-faces-of-ms/Living with multiple sclerosis often means experiencing symptoms that others cannot see. Austrian artist Gabriela Romagna shares her journey to an M...

4 Nov 32min

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

#189: New imaging in MS: understanding progression and finding better treatments | ECTRIMS 2026

How could new imaging in MS help us understand progression and develop better treatments? In this episode, I explore key insights from Daniel Reich's MSToronto2026 lecture and related research. Learn ...

28 Okt 15min

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

#188: Jan Van Amstel on EMSP's Four-Year Presidency and the Future of MS Advocacy in Europe

"Get rid of MS as soon as possible and make ourselves superfluous." — Jan van Amstel What can a stronger European voice achieve for people living with MS? In episode #188, EMSP President Jan van Amste...

21 Okt 31min

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

#187: Aging in multiple sclerosis: relapses, progression and treatment choices with Dr. Yi Chao Foong

Aging in multiple sclerosis brings new questions about relapses, gradual progression and treatment choices. In episode 187, Dr. Yi Chao Foong, an MS neurologist and researcher in Tasmania, explains wh...

14 Okt 29min

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

#186: Protecting nerve cells in multiple sclerosis: A new path toward neuroprotection with Prof. Manuel Friese

Why can multiple sclerosis progress even when relapses are well controlled? In episode 186, I speak with Prof. Manuel Friese about the next challenge in MS research: protecting nerve cells from damage...

7 Okt 43min

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

#185: Living with MS in Mexico – who gets diagnosed, who gets treated, and who gets left behind?

An MS diagnosis can depend on where you live, whether you can reach a neurologist and how quickly you can get an MRI. In this episode, Nele speaks with neurologist and neuroimmunologist Dr. Enrique Go...

30 Sep 36min

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

#184: MS treatment across the disease course – treat early, think long-term, don't give up too soon with Prof. Klaus Schmierer

Read the full blog post and interview here: https://ms-perspektive.de/en/184-klaus-schmierer/ How early should MS treatment start, how strongly should we treat, and is there ever a point when it becom...

23 Sep 41min

#183: Silent progression in MS. Can we really detect it early?

#183: Silent progression in MS. Can we really detect it early?

Can we detect gradual MS progression before it becomes obvious? In this episode, I look at what current research can — and cannot — tell us about subtle worsening without an obvious relapse. The key d...

16 Sep 34min

Populært innen Fakta

fastlegen
dine-penger-pengeradet
fryktlos
relasjonspodden-med-dora-thorhallsdottir-kjersti-idem
rss-strid
rss-ekteskapet
rss-bisarr-historie
foreldreradet
treningspodden
jakt-og-fiskepodden
rss-kunsten-a-leve
rss-kull
rss-orjasater
sinnsyn
mikkels-paskenotter
gravid-uke-for-uke
rss-flydilla
hverdagspsyken
rss-mind-body-podden
rss-impressions-2